US Stock MarketDetailed Quotes
NUVB.WS NUVATION BIO INC C/WTS 07/07/2027 (TO PUR COM)
- 0.0900
- +0.0009+1.01%
Close Nov 4 16:00 ET
0Market Cap0.00P/E (TTM)
0.0978High0.0890Low8.59KVolume0.0891Open0.0891Pre Close802.68Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.445052wk High0.00P/B0Float Cap0.035052wk Low--Dividend TTM0Shs Float2.7400Historical High--Div YieldTTM9.90%Amplitude0.0325Historical Low0.0930Avg Price1Lot Size
NUVATION BIO INC C/WTS 07/07/2027 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -113.47%-37.33M | 18.77%-15.7M | 29.25%-68M | 7.05%-15.03M | 42.49%-16.16M | 35.04%-17.49M | 22.46%-19.33M | -40.94%-96.11M | 31.14%-16.17M | -113.66%-28.09M |
| Net income from continuing operations | -2,140.76%-462.49M | 31.92%-14.79M | 27.25%-75.8M | 33.86%-13.79M | 27.77%-19.65M | 40.79%-20.64M | -2.03%-21.73M | -19.98%-104.2M | 17.06%-20.85M | -23.77%-27.2M |
| Operating gains losses | -409.89%-1.13M | 4,388.24%1.46M | 96.09%-348K | -66.67%-290K | -62.34%-388K | 115.26%364K | 99.44%-34K | -114.62%-8.91M | 95.38%-174K | -77.04%-239K |
| Depreciation and amortization | 335.71%244K | 3.57%58K | 11.56%222K | 12.24%55K | -1.79%55K | 16.67%56K | 21.74%56K | 8.15%199K | 13.95%49K | -20.00%56K |
| Other non cash items | 2,361,388.89%425.03M | -123.53%-38K | -123.51%-67K | -150.88%-29K | -101.86%-3K | -127.27%-18K | -1,800.00%-17K | -92.82%285K | -64.38%57K | 3,925.00%161K |
| Change In working capital | -1,458.09%-6.13M | -1,441.47%-4.61M | 115.67%540K | -883.15%-1.44M | 141.58%1.83M | -87.77%451K | 89.76%-299K | -171.92%-3.45M | -77.23%184K | -190.00%-4.4M |
| -Change in receivables | 152.11%272K | -374.06%-581K | -319.68%-1.22M | -395.56%-669K | -174.84%-238K | -198.29%-522K | -61.17%212K | 128.45%554K | 88.98%-135K | 73.77%318K |
| -Change in prepaid assets | 2,247.02%3.54M | -3,951.82%-5.28M | 2,066.98%2.3M | 14.04%1.45M | -79.47%555K | -53.68%151K | 103.26%137K | 104.39%106K | 303.03%1.28M | 85.46%2.7M |
| -Change in payables and accrued expense | -1,140.15%-8.55M | 368.06%1.74M | 101.14%47K | -132.85%-2.23M | 128.28%2.1M | -76.77%822K | -188.52%-648K | -144.10%-4.11M | -133.92%-956K | -328.55%-7.42M |
| -Change in other current assets | --0 | ---488K | ---587K | --0 | ---587K | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -113.46%-37.32M | 18.77%-15.7M | 29.25%-68M | 7.05%-15.03M | 42.49%-16.16M | 35.04%-17.49M | 22.46%-19.33M | -40.94%-96.11M | 31.14%-16.17M | -113.66%-28.09M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -8.23%34.27M | 114.50%7.54M | -85.94%8.92M | 251.92%33.16M | -114.94%-9.59M | 40.22%37.35M | -836.70%-52M | 113.96%63.46M | 88.47%-21.83M | 170.00%64.2M |
| Net PPE purchase and sale | --0 | -125.00%-27K | 84.59%-55K | 101.69%1K | 77.08%-22K | 88.72%-22K | -71.43%-12K | -26.60%-357K | 56.30%-59K | -231.03%-96K |
| Net investment purchase and sale | -41.79%21.75M | 114.56%7.57M | -85.93%8.98M | 252.33%33.16M | -114.88%-9.57M | 39.28%37.37M | -837.66%-51.98M | 114.04%63.81M | 88.49%-21.77M | 170.12%64.3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -8.23%34.27M | 114.50%7.54M | -85.94%8.92M | 251.92%33.16M | -114.94%-9.59M | 40.22%37.35M | -836.70%-52M | 113.96%63.46M | 88.47%-21.83M | 170.00%64.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,966.17%2.75M | -92.95%21K | -52.68%628K | -70.52%120K | -70.16%77K | 103.69%133K | -93.01%298K | -99.79%1.33M | -24.35%407K | 906.25%258K |
| Proceeds from stock option exercised by employees | 1,430.08%2.04M | -92.95%21K | -52.68%628K | -70.52%120K | -70.16%77K | -61.78%133K | -5.10%298K | 75.07%1.33M | -24.35%407K | 760.00%258K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,966.17%2.75M | -92.95%21K | -52.68%628K | -70.52%120K | -70.16%77K | 103.69%133K | -93.01%298K | -99.79%1.33M | -24.35%407K | 906.25%258K |
| Net cash flow | ||||||||||
| Beginning cash position | 14.76%34.51M | -57.81%42.65M | -23.65%101.1M | -82.41%24.4M | -51.07%50.07M | -71.69%30.07M | -23.65%101.1M | 345.04%132.42M | -59.76%138.69M | -77.24%102.32M |
| Current changes in cash | -101.52%-303K | 88.54%-8.14M | -86.60%-58.45M | 148.56%18.25M | -170.58%-25.67M | 614.51%19.99M | -170.93%-71.03M | -130.51%-31.32M | 82.29%-37.59M | 134.67%36.37M |
| End cash Position | -31.52%34.29M | 14.76%34.51M | -57.81%42.65M | -57.81%42.65M | -82.41%24.4M | -51.07%50.07M | -71.69%30.07M | -23.65%101.1M | -23.65%101.1M | -59.76%138.69M |
| Free cash flow | -113.19%-37.32M | 18.68%-15.73M | 29.45%-68.07M | 7.34%-15.04M | 42.62%-16.18M | 35.43%-17.51M | 22.43%-19.34M | -40.90%-96.48M | 31.26%-16.23M | -113.97%-28.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data